Assay-kits

SensoLyte® 490 MMP-3 Assay Kit Fluorimetric - 1 kit

$804.00
Check your price
  • Cat.Number : AS-71130
  • Availability :
    In production
  • Shipping conditions : Ice fees will apply

Alternative choices

Quantity

Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated proteins capable of digesting extracellular matrix components. The importance of MMPs in tumor development and invasion as well as other diseases is well known. MMP-3 (stromelysin-1, transin-1) is proposed as a potential therapeutic target. The SensoLyte® 490 MMP-3 Assay Kit is a complete assay system designed to continuously analyze MMP activities or to screen MMP-3 inhibitors using a fluorogenic MMP-3 substrate.

Specifications

Packaging
Kits components
  • Component A: MMP-3 substrate: 270 µL Component B: EDANS, fluorescence reference standard Ex/Em=340 nm/490 nm: 1 mM, 10 µL Component C: APMA, 4-aminophenylmercuric acetate: 1 M, 100 µL Component D: Assay buffer: 60 mL Component E: Stop solution: 30 mL
Chemistry
UniProt number
  • P08254
Properties
Absorbance (nm)
  • 340
Emission (nm)
  • 490
Storage & stability
Storage Conditions
  • Store all components at -20°C. Protect components A and B from light. Components D and E can be stored at 4 °C for convenience.
Activity
Application
Biomarker Target
Detection Method
Research Area
Sub-category Research Area
Usage
  • Research use

You may also be interested in the following product(s)

IMG-EN-AS-60431-1-01.jpg

ADAMTS-4/Aggrecanase FRET Substrate, WAAG-3R - 1 mg

Cat.Number : AS-60431-1
$296.00 Excl. Tax
IMG-EN-AS-72006-01.jpg

Human MMP-3 - 100 µL

Cat.Number : AS-72006
$124.00 Excl. Tax
IMG-EN-AS-71152-01.jpg

SensoLyte® 520 MMP-3 Assay Kit Fluorimetric - 1 kit

Cat.Number : AS-71152
$554.00 Excl. Tax

Citations

Association of Matrix metalloproteinase-3 with cardiogenic activity during Noggin-induced differentiation of mouse embryonic stem cells

Int J Cardiol. . 2009 Jan 12 ; 141(1) 49 | DOI : 10.1016/j.ijcard.2008.11.156

  • S. Hong

Avenanthramide C as a novel candidate to alleviate osteoarthritic pathogenesis.

BMB Rep. . 2021 Oct 03 ; 54(10) 528 | DOI : 10.5483/BMBRep.2021.54.10.108

  • TT. Tran
  • et al